Inactive Instrument
Probi AB Stock OTC Markets
Stocks
PBBIF
SE0001280355
Pharmaceuticals
OTC Markets Traded| 1 day | +31.67% |
| Manager | Title | Age | Since |
|---|---|---|---|
Anita Johansen
CEO | Chief Executive Officer | 54 | 2022-12-07 |
Johan Flink
DFI | Director of Finance/CFO | 49 | 2025-07-31 |
Christina Vegge
CTO | Chief Tech/Sci/R&D Officer | 53 | 2023-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 2020-05-12 | |
| Chairman | 62 | 2015-03-31 | |
| Director/Board Member | 64 | 2017-05-03 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +31.67% | +85.88% | - | - | 33.68M | ||
| -2.41% | +0.14% | +38.28% | +154.20% | 1,010B | ||
| +1.07% | +3.48% | +53.32% | +49.85% | 580B | ||
| +1.32% | +0.22% | +19.18% | +64.65% | 402B | ||
| +0.77% | 0.00% | +21.28% | +16.70% | 330B | ||
| +0.44% | +3.48% | +25.65% | +35.66% | 281B | ||
| -0.85% | -2.86% | +22.54% | +14.67% | 280B | ||
| +1.66% | +1.20% | -44.35% | -47.35% | 197B | ||
| +0.32% | +1.61% | +20.32% | +60.01% | 192B | ||
| -0.22% | -2.76% | +14.19% | +60.09% | 156B | ||
| Average | +3.38% | +0.84% | +18.93% | +45.39% | 380.99B | |
| Weighted average by Cap. | -0.23% | +1.04% | +27.77% | +70.54% |
Employees
-
Sector
Pharmaceuticals
















